| NIMH | National Institute of Mental Health |
| NDA | National Institute of Mental Health Data Archive |
| TCGA | The Cancer Genome Atlas |
| TCIA | The Cancer Imaging Archiv |
| GBM | Glioblastoma multiforme |
| LGG | Low-grade glioma |
| MRI | Magnetic resonance imaging |
| mRNA | Messenger ribonucleic acid |
| microRNA | Micro ribonucleic acid |
| IPA | Ingenuity pathway analysis |
| POSTN | Periostin |
| KPS | Karnofsky performance status |
| VAK | Volume, Age, and KPS |
| MGMT | O6-methylguanine-DNA-methyltransferase |
| EGFR | Epidermal growth factor receptor |
| rCBVner | Relative cerebral blood volume of non-enhancing region |
| OS | Overall survival |
| PS | Permeability surface |
| CBV | Cerebral blood volume |
| VEGF | Vascular endothelial growth factor |
| HIF1A | Hypoxia-inducible factor 1-alpha |
| VASH2 | Vasohibin-2 |
| C3 | Complement component 3 |
| AMOT | Angiomotin |
| NF1 | Neurofibromin 1 |
| WHO | World health organization |
| rCBV | Relative cerebral blood volume |
| PTEN | Phosphatase and tensin homolog |
| COL15A1 | Collagen alpha-1(XV) chain |
| SPARC | Secreted protein acidic and rich in cysteine |
| ANPEP | Alanyl aminopeptidase |
| CBFB | Core-binding factor subunit beta |
| STRN | Striatin |
| TMED10 | Transmembrane P24 trafficking protein 10 |
| EGF | Epithelial growth factor |
| ARAF | A-Raf proto-oncogene |
| TRAF | TNF receptor-associated factor 1 |
| ROI | Region of interest |
| GAP43 | Growth associated protein 43 |
| WWTR1 | WW domain-containing transcription regulator 1 |
| TP53 | Tumor protein P53 |
| PGC1alpha | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PAR1 | Prader Willi/Angelman region RNA 1 |
| HOXC6 | Homeobox C6 |
| RB1 | Retinoblastoma protein |
| PDGFRA | Platelet-derived growth factor receptor A |
| AUC | Area under the curve |
| HRAS | Harvey rat sarcoma viral oncogene homolog |
| PARADIGM | Pathway recognition algorithm using data integration on genomic models |
| VEGFR | Vascular endothelial growth factor receptor |
| Ang | Angiopoietin |
| Tie2 | Tyrosine-protein kinase receptor Tie-2 |
| WNT | Wnt family member 1 |
| IRF9 | Interferon regulatory factor 9 |
| XRCC1 | X-ray cross-complementing |
| PsP | Pseudoprogression |
| TTP | True tumor progression |
| GSEA | Gene set enrichment analysis |
| PWI | Perfusion weighted imaging |
| ANG | Angiogenin |
| TGFB2 | Transforming growth factor-beta 2 |
| BEVR | Bounding ellipsoid volume ratio |
| BEDR1 | Bounding ellipsoid diameter ratio 1 |
| BEDR2 | Bounding ellipsoid diameter ratio 2 |
| MF | Margin fluctuation |
| ASD | Angular standard deviation |
| AMKP | AMP-activated protein kinase |
| PI3k | Phosphoinositide 3-kinase |
| AKT | Serine/threonine kinase 1 |
| mTOR | Mechanistic target of rapamycin kinase |
| NGF | Nerve growth factor; Phosphatidylinositol-4,5-bisphosphate 3-kinase |
| AKT | RAC-alpha serine/threonine-protein kinase |
| IL-8 | Interleukin 8 |
| CGGA | Chinese glioma genome atlas |
| TIMP1 | TIMP metallopeptidase inhibitor 1 |
| ROS1 | ROS proto-oncogene 1 |
| EREG | Epiregulin |
| DCE | Dynamic contrast-enhanced |
| PET | Positron emission tomography |
| BPE | Breast parenchymal enhancement |
| GLCM | Gray-level-co-occurrence matrix |
| PR | Progesterone receptor |
| CDK4 | Cyclin-dependent kinase 4 |
| BCL2 | B-cell lymphoma 2 |
| ER | Estrogen receptor |
| BI-RADS | Breast imaging reporting and data system |
| AR | Androgen receptor |
| ESR1 | Estrogen receptor 1 |
| IL6- | Interleukin 6 |
| DDIT4 | DNA damage-inducible transcript 4 |
| ccRCC | Clear cell renal cell carcinoma |
| pRCC | Papillary renal cell carcinoma |
| RCC | Renal cell carcinoma |
| VHL | Von Hippel–Lindau |
| CT | Computed tomography |
| BAP1 | BRCA1 associated protein 1 |
| MUC4 | Mucin 4, Cell surface associated |
| ANN | Artificial neural network |
| RF | Random forest |
| PBRM | Polybromo-1 |
| CLOVAR | Classification of ovarian cancer |
| CIN | Contrast-induced nephropathy |
| CER | Contrast-enhancing ratio |
| CEV | Contrast-enhancing volume |